Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

5-[1-(2,6-dichlorobenzyl)piperidin-4-ylmethoxy]quinazoline-2,4-diamine dihydrochloride

EU orphan designation number: EU/3/11/892   
Active ingredient: 5-[1-(2,6-dichlorobenzyl)piperidin-4-ylmethoxy]quinazoline-2,4-diamine dihydrochloride
Indication: Treatment of 5q spinal muscular atrophy
Sponsor: Repligen Europe Limited
25/28 North Wall Quay, Dublin 1, Dublin Co., Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
1/09/2011 Orphan designation EMA/OD/009/11 (2011)6278 of 30/08/2011